The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index; 39 of the 51 sources its claims cite were checked for support.
Progress on the correlation between sepsis and gut microbiota: a narrative review
Open accessAbstract
Background: Sepsis is a life-threatening organ dysfunction with high mortality. Gut microbiota plays a key role in sepsis pathogenesis, but evidence is often mixed. Methods: This narrative review is based on a structured literature search (PubMed, Web of Science, Cochrane; from database inception to March 15, 2025). Findings are stratified into clinical (human), preclinical (animal), and unsafe/unproven categories. Results: Sepsis and gut microbiota form a bidirectional vicious cycle. Sepsis induces dysbiosis via ischemia, inflammation, and broad-spectrum antibiotics - the strongest iatrogenic driver. Dysbiosis in turn amplifies organ dysfunction through gut-brain, gut-lung, gut-liver, gut-kidney, and gut-heart/spleen axes. Clinically, adequate source control and antibiotic de-escalation are mandatory before any microbiota-directed therapy. Microbiota-targeted interventions show promise but carry significant risks: live probiotics are contraindicated in septic shock, severe pancreatitis, and immunocompromised patients (PROPATRIA trial). Conclusion: This evidence-stratified review provides a clinical roadmap: prioritize source control and antibiotic stewardship; avoid live probiotics in high-risk sepsis. Future research requires large RCTs and personalized strategies.
Overview
CoChat Summary
## TL;DR
This narrative review argues that sepsis and gut microbiota reinforce each other in a vicious cycle: sepsis drives dysbiosis, and dysbiosis worsens organ dysfunction through barrier failure, immune-metabolic disruption, and gut-organ axes. The review concludes that source control and antibiotic stewardship come before any microbiota-directed therapy, and that live probiotics should be avoided in high-risk septic patients.
## Key findings
- Sepsis-induced dysbiosis is driven by ischemia/reperfusion injury, systemic inflammatory mediators, and iatrogenic factors; the review identifies broad-spectrum antibiotics as the strongest iatrogenic driver of dysbiosis.
- Dysbiosis can amplify organ failure through multiple gut-organ axes, including gut-brain, gut-lung, gut-liver, gut-kidney, and gut-heart/spleen pathways.
- Clinically, source control and antibiotic de-escalation are mandatory before microbiota-directed therapy; the paper also notes that inadequate source control makes microecological interventions unlikely to succeed and potentially harmful.
- Live probiotics are flagged as unsafe in high-risk settings: in the PROPATRIA trial, severe acute pancreatitis patients had increased gut necrosis (9/152 vs. 0/144) and mortality (24/152 vs. 9/144); the review says they should not be routinely used in septic shock, severe acute pancreatitis, or immunocompromised patients.
## Methods
- Narrative review based on a structured literature search of PubMed, Web of Science, and Cochrane Library from database inception to March 15, 2025.
- Included clinical studies, animal experiments, and mechanistic studies; case reports and non-microbiome studies were excluded.
- Findings were stratified into clinical (human), preclinical (animal), and unsafe/unproven categories, with evidence graded throughout as clinical, preclinical, clinical/preclinical, or clinical warning.
## Limitations
- The paper states that relevant studies remain scarce, and that the specific mechanisms and clinical implications are still unclear.
- It explicitly notes that evidence for many interventions is limited: synbiotics have only small studies, FMT for sepsis has only preclinical/animal studies, and human trials are lacking for postbiotics.
- Evident from the text: as a narrative review, it synthesizes heterogeneous studies rather than presenting new patient-level data or a quantitative meta-analysis.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
26 Valid · 8 Not valid · 7 Not checked · 15 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“For sepsis itself, only preclinical/animal studies exist (Han et al., 2024; Qian et al., 2025).”
§ Progress on the correlation between sepsis and gut microbiota: a narrative review > Microbiota-targeted intervention strategies > Fecal microbiota transplantation (FMT)
What the sources say
- Disputedcites Han et al., 2024 sourceExperimental — accuracy not yet measured
The Introduction (page not provided) says that, although there are no large-scale clinical FMT studies in critically ill patients, a limited number of case reports exist. The References (page not provided) identify case reports involving patients with severe sepsis, contradicting the claim that only animal studies of FMT for sepsis exist. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
- Partly supportedcites Qian et al., 2025 sourceExperimental — accuracy not yet measured
The Methods section (no page available) describes FMT using septic donor mice and mouse recipients, so Qian et al. is a preclinical FMT study. It does not establish that only animal studies of FMT for sepsis exist; its References section (no page available) also lists FMT treatment in patients following severe sepsis, though that report concerns post-sepsis complications. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Gut dysbiosis is not a passive consequence but an active driver of sepsis aggravation, primarily through barrier dysfunction, immune-metabolic disturbances, and amplified systemic inflammation”
§ Progress on the correlation between sepsis and gut microbiota: a narrative review > Bidirectional interplay between sepsis and gut microbiota > Role of gut microbiota dysbiosis in promoting sepsis
What the sources say
- Partly supportedcites Niu and Chen, 2021 sourceExperimental — accuracy not yet measured
The Review section 'Sepsis may aggravate gut microbiome dysbiosis' says disrupted gut ecosystems could promote septic organ damage and that reduced short-chain fatty acids could worsen barrier function and affect systemic immunity. 'Gut microbiota modulate sepsis progression' also links microbial metabolites to immune regulation and inflammation. The paper treats dysbiosis as a possible contributor, however; it does not establish it as an active driver acting primarily through the three stated pathways. (LLM, conf=0.84)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“each hour delay in upper GI perforation raises mortality by 6% (Coccolini et al., 2023).”
§ Progress on the correlation between sepsis and gut microbiota: a narrative review > Clinical integration: source control and antibiotic stewardship > Source control in intra-abdominal sepsis
What the sources say
- Supportedcites Coccolini et al., 2023 source
The “Timings and priorities of SC” section states that, for upper gastro-enteric perforations, each additional hour of delay to operative source control was associated with a 6% increase in mortality. The claim is a close paraphrase, though the paper describes an association rather than establishing causation. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Sepsis induces dysbiosis via ischemia, inflammation, and broad-spectrum antibiotics”
- Also stated in: § Effects of sepsis on gut microbiota · plain
“Intestinal ischemia and reperfusion injury: Early sepsis reduces effective circulating blood volume and causes microcirculatory dysfunction.”
§ Progress on the correlation between sepsis and gut microbiota: a narrative review > Abstract > Results
What the sources say
- Not matchedcites Li et al., 2024
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites Zhang et al., 2022 sourceExperimental — accuracy not yet measured
The ‘Effects of sepsis on the intestinal barrier and microbiota’ section reports microbiota dysbiosis in septic patients. The paper does not link that dysbiosis to ischemia; its discussion of ischemia concerns liver injury, not the gut microbiota. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Effects of sepsis on gut microbiota · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“Sepsis and gut microbiota form a bidirectional vicious cycle.”
- Also stated in: § Bidirectional interplay between sepsis and gut microbiota · plain
“Sepsis and the gut microbiota exhibit a close bidirectional interaction, often forming a self-reinforcing vicious cycle”
§ Progress on the correlation between sepsis and gut microbiota: a narrative review > Abstract > Results
What the sources say
- Supportedcites Lou et al., 2023 source
The ‘Gut microbiota–sepsis interactions’ section says sepsis can disturb the intestinal microbiota and that the resulting dysfunction and disturbance influence one another. It also describes gut bacteria entering circulation and worsening sepsis, supporting the bidirectional vicious-cycle characterization. Page numbers were not supplied. (LLM, conf=0.92)
- Supportedcites Zhao et al., 2023 source
The Discussion says that gut-microbiome perturbations increase susceptibility to sepsis and that sepsis, in turn, deranges the microbiome, worsening illness and vulnerability. This supports the paraphrase of a bidirectional vicious cycle. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Bidirectional interplay between sepsis and gut microbiota · plain
24 more claims · 15 with their cited sources checked
Create a free account to see all 56 claims and every source verdict.
- It may state two separate claims as one. 17
- Probably not a substantial claim. 10
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250 · cited 1×
“Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection (Singer et al., 2016).”
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Decontamination of the digestive tract and oropharynx in ICU patients
de Smet, A. M. G. A., Kluytmans, J. A. J. W., Cooper, B. S., Mascini, E. M., Benus, R. F. J., van der Werf, T. S., van der Hoeven, J. G., Pickkers, P., Bogaers-Hofman, D., van der Meer, N. J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0800394 · Cited by 813
Quraishi, M. N., Widlak, M., Bhala, N., Moore, D., Price, M., Sharma, N., & Iqbal, T. H. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14201 · Cited by 617 · cited 1×
“Table 2 provides a systematic summary of key clinical studies (PROPATRIA trial Besselink et al., 2008; van Nood et al., 2013; Quraishi et al., 2017; de Smet et al., 2009; Widhani et al., 2022), detailing sample sizes, intervention protocols, primary endpoints, and safety data.”
The gut microbiota-immune-brain axis: therapeutic implications
O’Riordan, K. J., Moloney, G. M., Keane, L., Clarke, G., & Cryan, J. F. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101982 · Cited by 333
Immunopathophysiology of human sepsis
Wiersinga, W. J., & van der Poll, T. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104363 · Cited by 322
Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
Shen, Y., Fan, N., Ma, S., Cheng, X., Yang, X., & Wang, G. (2025) · MedComm · doi:10.1002/mco2.70168 · Cited by 301 · cited 1×
“Moreover, gut microbiota communicate bidirectionally with distant organs via “gut-organ axes” (e.g., gut-lung, gut-liver), influencing organ function in disease states (Cheng et al., 2023; Shen et al., 2025; Zhou et al., 2021).”
Gut-liver crosstalk in sepsis-induced liver injury
Sun, J., Zhang, J., Wang, X., Ji, F., Ronco, C., Tian, J., & Yin, Y. (2020) · Critical Care · doi:10.1186/s13054-020-03327-1 · Cited by 246 · cited 1×
“…often presents as jaundice, coagulopathy, and metabolic disturbances, while nutritional disorders (muscle wasting, hypoalbumin-emia, abnormal glucose/lipid metabolism, negative nitrogen balance) are common and closely linked to gut-liver axis impairment (Zhang et al., 2022; Sun et al., 2020).”
WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections
Sartelli, M., Coccolini, F., Kluger, Y., Agastra, E., Abu-Zidan, F. M., Abbas, A. E. S., Ansaloni, L., Adesunkanmi, A. K., Atanasov, B., Augustin, G., et al. (2021) · World Journal of Emergency Surgery · doi:10.1186/s13017-021-00387-8 · Cited by 207 · cited 6×
“For specific IAIs (appendicitis, diverticulitis, etc.), the WSES/ GAIS global clinical pathways provide detailed algorithms (Sartelli et al., 2021).”
Influential
Metadata
- Authors
- Yuan, Y., Li, J., & Yang, C.
- Affiliations
- Sichuan University (CN)
- Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education
- Corresponding author
- Yang, Cheng
- ORCID
- Yang, Cheng
- Venue
- Frontiers in microbiology
- Publisher
- Frontiers Media SA
- Published
- 2026-06-03
- Volume
- 17
- Pages
- 1862891-1862891
- ISSN
- 1664-302X (ISSN-L)
- PMC
- PMC13272164
- OpenAlex
- W7163393789
- Semantic Scholar
- a69f372c456f9e9220a3cd3c072a48fa4d1a9a2e
- Cited by
- 1
- References
- 58
- Citations by year
- 2026: 1
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Microbiology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
- Keywords
- sepsis, gut microbiota, dysbiosis, gut-brain axis, gut-lung axis, gut-liver axis, gut-kidney axis, gut-heart axis, septic shock, antibiotic de-escalation, antibiotic stewardship, source control, probiotics, immunocompromised patients, severe pancreatitis, organ dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress on the correlation between sepsis and gut microbiota: a narrative review. https://app.cochat.ai/papers/10.3389/fmicb.2026.1862891
- The paper
- Yuan, Y., Li, J., & Yang, C. (2026). Progress on the correlation between sepsis and gut microbiota: a narrative review. Frontiers in microbiology. https://doi.org/10.3389/fmicb.2026.1862891
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.